NDC 0832-0532 – Imatinib mesylate
Imatinib Mesylate 100 mg/1 · Tablet · Oral
Product NDC0832-0532
Product details
- Brand name
- Imatinib mesylate
- Generic name
- Imatinib mesylate
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA212135
- Marketed since
- May 17, 2024
- Marketing end
- January 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Imatinib Mesylate 100 mg/1
Uses, dosage, side effects and warnings for Imatinib mesylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0832-0532-09 | 90 TABLET in 1 BOTTLE (0832-0532-09) | May 17, 2024 |
Other Imatinib mesylate products
- 72819-185 Imatinib Mesylate 100 mg/1 · Tablet · Archis Pharma LLC
- 72819-186 Imatinib Mesylate 400 mg/1 · Tablet · Archis Pharma LLC
- 66828-0303 Imatinib Mesylate 100 mg/1 · Tablet · Novartis Pharma Produktions GmbH
- 66828-0310 Imatinib Mesylate 400 mg/1 · Tablet · Novartis Pharma Produktions GmbH
- 67184-0533 Imatinib Mesylate 400 mg/1 · Tablet · Qilu Pharmaceutical Co., Ltd.
- 67184-0532 Imatinib Mesylate 100 mg/1 · Tablet · Qilu Pharmaceutical Co., Ltd.
- 0832-0533 Imatinib Mesylate 400 mg/1 · Tablet · Upsher-Smith Laboratories, LLC
- 60687-882 Imatinib Mesylate 100 mg/1 · Tablet, Film Coated · American Health Packaging
- 60505-2901 Imatinib Mesylate 400 mg/1 · Tablet, Film Coated · Apotex Corp
- 60505-2900 Imatinib Mesylate 100 mg/1 · Tablet, Film Coated · Apotex Corp
- 72485-203 Imatinib Mesylate 400 mg/1 · Tablet, Film Coated · Armas Pharmaceuticals Inc.
- 72485-202 Imatinib Mesylate 100 mg/1 · Tablet, Film Coated · Armas Pharmaceuticals Inc.